Now Accepting Letters of Intent for 2027 Research Grants! Explore Funding Opportunities
SCA8 Treatment Pipeline Tracking progress of the development of SCA8 therapies. Pipeline for SCA8 This is a visual tool created to show the progress of SCA8 therapies that are currently Read More…
SCA7 Treatment Pipeline Tracking progress of the development of SCA7 therapies. Pipeline for SCA7 This is a visual tool created to show the progress of SCA7 therapies that are currently Read More…
SCA6 Treatment Pipeline Tracking progress of the development of SCA6 therapies. Pipeline for SCA6 This is a visual tool created to show the progress of SCA6 therapies that are currently Read More…
SCA3 Treatment Pipeline Tracking progress of the development of SCA3 therapies. Pipeline for SCA3 This is a visual tool created to show the progress of SCA3 therapies that are currently Read More…
2023 Annual Ataxia Conference March 30 – April 1, 2023 SESSIONS SPEAKERS HOTEL SPONSORS REGISTER>> First Hybrid AAC Was a Huge Success As interest continues to grow from the pharmaceutical Read More…
SCA1 Treatment Pipeline Tracking progress of the development of SCA1 therapies. Pipeline for SCA1 This is a visual tool created to show the progress of SCA1 therapies that are currently Read More…
Ataxia Treatment Pipeline Tracking progress of the development of Ataxia therapies. Treatment development is a long process that involves multiple phases of a clinical trial and oversight by the Food Read More…
Breaking Pharma News Informing the Ataxia community about drug development RECENT 2024 & OLDER ATAXIA RESEARCH OPPORTUNITIES Recent Ataxia Pharma News FDA Accepts Troriluzole Resubmission for Review October 22, 2026 Read More…
Ataxia research news, directly from researchers to the Ataxia community. Glossary Contact >> Recent Articles View All SCAsource Articles Want to receive an email each time SCAsource publishes a new Read More…
$1 million annual fund to accelerate our ability to improve the lives of those living with Ataxia. DONATE TO ACCELERATE! WHAT IS ACCELERATE? Accelerate is designed to raise funds in Read More…
